(Q43063060)

English

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis

scientific article published on 12 May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

13 November 2017

0 references

0 references

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

pneumococcal vaccine

1 reference

based on heuristic

inferred from title

Evangelia Farmaki

object named as

Evangelia Farmaki

1

0 references

author name string

Florentia Kanakoudi-Tsakalidou

2

1 reference

Europe PubMed Central

13 November 2017

Vana Spoulou

3

1 reference

Europe PubMed Central

13 November 2017

Maria Trachana

4

1 reference

Europe PubMed Central

13 November 2017

Polyxeni Pratsidou-Gertsi

5

1 reference

Europe PubMed Central

13 November 2017

Maria Tritsoni

6

1 reference

Europe PubMed Central

13 November 2017

Maria Theodoridou

7

1 reference

Europe PubMed Central

13 November 2017

language of work or name

0 references

publication date

12 May 2010

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

28

1 reference

Europe PubMed Central

13 November 2017

31

1 reference

Europe PubMed Central

13 November 2017

5109-5113

1 reference

Europe PubMed Central

13 November 2017

Novel therapies in pediatric rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Infections and anti–tumor necrosis factor α therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Vaccination and autoimmune rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Pneumococcal vaccination for RA patients on TNF-alpha antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Preliminary definition of improvement in juvenile arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Variation in vaccine response in normal populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Should the new pneumococcal vaccine be used in high-risk children?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Vaccination of the immunocompromised child

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Vaccination in patients with chronic rheumatic or autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.080

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.03.080

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43063060&oldid=1979177626"